MUC16 and ovarian serous adenocarcinoma: Although intact MUC16 seems to be the dominant form on high grade serous ovarian cancer, our previous data suggest that a small fraction of cell surface MUC16 molecules may lack tandem repeat immunoreactivity but retain reactivity to MUC16ecto targeted antibodies like 4H11 [24].